Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Biochimica Et Biophysica Acta|July 29, 2006
Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validationPeter Verheesen, Andreas Roussis, Hans J de Haard, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 9, 2014
Selection and characterization of llama single domain antibodies against N-terminal huntingtinMenno H Schut, Barry A Pepers, Rinse Klooster, et al.
The Journal of Experimental Medicine|May 30, 2012
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunizationLaura E McCoy, Anna Forsman Quigley, Nika M Strokappe, et al.
Neurobiology of Aging|December 18, 2009
Differential recognition of vascular and parenchymal beta amyloid depositionKim S Rutgers, Alexandra van Remoortere, Mark A van Buchem, et al.
European Journal of Human Genetics : EJHG|April 14, 2005
Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage displayYanchao Huang, Peter Verheesen, Andreas Roussis, et al.
Plos Pathogens|December 19, 2014
Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1Laura E McCoy, Lucy Rutten, Dan Frampton, et al.
Frontiers in Immunology|June 2, 2022
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector FunctionsAngela I Schriek, Marlies M van Haaren, Meliawati Poniman, et al.
Frontiers in Immunology|December 9, 2022
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functionsAngela I Schriek, Marlies M van Haaren, Meliawati Poniman, et al.
ACS Infectious Diseases|June 8, 2017
Unravelling the Molecular Basis of High Affinity Nanobodies against HIV p24: In Vitro Functional, Structural, and in Silico InsightsEleanor R Gray, Jennifer C Brookes, Christophe Caillat, et al.
Plos One|April 13, 2011
Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral moleculesAnna Hultberg, Nigel J Temperton, Valérie Rosseels, et al.
Pageof 8